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Introduction: Complete abdominal wall infiltration with neoplastic gastrocutaneous fistula is an unexpected and
out of the ordinary presentation of locally advanced gastric cancer. It is very rare to encounter case reports
presenting diffuse abdominal wall invasion, but a complete parietal destruction is an exceptional event.
Case presentation: Here we describe the case of an 81-year-old Caucasian woman presenting a carcinoma
perforating her anterior gastric wall and infiltrating all layers of her abdominal wall. The gastric tumor infiltrated
her transverse mesocolon, the rectus abdominis muscles bilaterally and overran them anteriorly, causing a large
parietal deficit and a complete external fistula. Treatment consisted of a complex surgical procedure requiring
general and reconstructive surgery cooperation in order to perform an en bloc gastric resection including colon and
abdominal wall, followed by a parietal reconstruction through positioning of prosthesis and reverse abdominoplasty.
Conclusions: Clinical presentation, histology and therapeutic options are discussed. The importance of a
multidisciplinary approach when encountering extremely rare clinical presentations is emphasized.
Keywords: Advanced gastric cancer, Biological prosthesis, Multidisciplinary approach, Neoplastic gastrocutaneous
fistula, Reverse abdominoplastyIntroduction
Gastric adenocarcinoma is one of the main causes of
cancer-related mortality [1-4]. In some patients diagno-
sis can be difficult due to various clinical presentations
[5-11], some of which are correlated to poor prognosis.
Here we report the unusual case of a patient with gastric
cancer presenting a large abdominal extramural growth
together with a gastrocutaneous fistula.Case presentation
An 81-year-old Caucasian woman with a medical history
of hypertension and cholecystectomy for perforated acute
cholecystitis was admitted to a community medical ward.
At the time, she presented with asthenia, weight loss,
occasional vomiting, abdominal pain and anemia. At* Correspondence: nicola.anita@tiscali.it
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unless otherwise stated.clinical examination a parietal swelling was observed
and at surgical consultation an incisional hernia through
the previous cholecystectomy incision was suspected. A
gastroscopy revealed the presence of a neoplasm shrinking
the gastric antrum. In the following days a small cutane-
ous ulcer above the parietal swelling was observed
followed by the appearance of a fistula a few days later.
After surgical consultation she was moved to our
university surgical ward.
Our laboratory tests revealed hypoproteinemia (4.6g/dL),
hypoalbuminemia (2g/dL) and anemia (8.3g/dL) which
required transfusion of three blood units. A computed
tomography (CT) scan (Figure 1) showed a huge mass
(10×14×15cm) arising from her gastric antrum, without
a clear cleavage from the left lobe of her liver with
internal necrosis and hemorrhage. The mass appeared
to infiltrate her transverse mesocolon and her rectus
abdominis muscles bilaterally, and to overrun them
anteriorly causing a large parietal deficit and a completentral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Computed tomography scan: huge mass arising from the gastric antrum, infiltrating and perforating the abdominal wall.
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large vessel infiltration or distant metastases.
At surgery, laparotomy was performed using a skin
elliptical incision centered from the neoplastic lesion
surrounded by 2cm of healthy perilesional skin tissueFigure 2 Preoperative planning: horizontal skin ellipse with 2cm mar(Figure 2). Lateral margins of elliptical incision were
enlarged with two other linear incisions.
An en bloc resection of stomach, colon and abdominal
wall was performed (Figure 3) along with systematic lymph
node dissection, followed by mechanic gastrojejunostomygin of healthy perilesional skin tissue.
Figure 3 Specimen of en bloc resection of stomach, transverse colon, rectus abdominis and soft tissue of the abdominal wall.
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drains were positioned and the parietal defect (Figure 4)
was reconstructed by positioning a biological pros-
thesis. The skin defect was closed with reverse abdomi-
noplasty flap [12] (Figure 5). The intra-abdominal
pressure (IAP) through intravesical measurement was
lower than 10mmHg during the operation and during
the postoperative course.
Histology reported a poorly differentiated adenocarcin-
oma with growth pattern and differentiation phenotype
of neuroendocrine type. At microscopy, extension had
reached the transverse colon mucosa and the extraserosal
tissues up to the skin. (Figure 6a-c). The immunohisto-
chemistry was positive for pan-cytokeratin chromogranin
and CD56, (Figure 6d) while negative for vimentin, synap-
tophysin and S-100.
The immediate postoperative course was satisfactory.
The patient did not present relevant laboratory abnor-
malities except for a mild anemia which was treated with
hemotransfusions on the first three postoperative days.
On day 3 her bowel movements began. On day 6, after
an oral X-ray contrast examination, she started drinking
and eating.Unfortunately, on day 10 she experienced severe
respiratory distress that resulted in pneumonia. Despite
antibiotic therapy and her transfer to the intensive care
unit, she died 20 days after surgery (Additional file 1).
Conclusions
Although gastric cancer often presents itself at an ad-
vanced stage of disease [3,4], full abdominal wall infiltra-
tion along with its destruction and a wide gastrocutaneous
fistula is rarely observed. In general, cancer infiltrates ab-
dominal organs by way of diffusion to adjacent tissues and
invasion of the superficial serosal layer [5]. Only a few
cases of gastric cancer with uncommon clinical presenta-
tions have been reported in the literature and these in-
cluded gastrointestinal obstruction [6-9], proctorrhagia,
straining and rectal tenesmus [10]. To the best of our
knowledge, our patient’s gastric cancer presentation as
extramural diffusion and abdominal wall fistula is a very
rare occurrence. Waguri et al. [11] reported the case of a
62-year-old man affected by gastric cancer and treated
with a weekly low-dose paclitaxel who presented with
diffuse abdominal wall invasion, but without a complete
parietal destruction.
Figure 4 Residual parietal defect after resection.
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extremely large dimensions or rapid growth have often
revealed – at histology – gastrointestinal stromal tumors
(GISTs) [13,14] rather than adenocarcinoma. Of interest,
none of the above revealed GISTS of the neuroendocrine
type as in our reported case.
In advanced gastric cancer possible therapeutic options
include neoadjuvant chemotherapy with gastrostomy or
jejunostomy. However, although evaluated by a multi-
disciplinary team, such a standard approach would not
have been feasible in our case due to the fact that the
huge parietal defect, the perforation, the stenosis and,
above all, the transverse colon involvement represented
a contraindication to performing either a gastrostomy
or a jejunostomy. The massive cancer infiltration of the
wall and surrounding organs, without great vessels infil-
trations, led us to perform a gastric resection including
transverse colon, rectus abdominis muscles and skin.
The large parietal defect was reconstructed by posi-
tioning a biological prosthesis which is the gold standard
procedure when tissue contamination is present or high
risk of anastomotic dehiscence exists [15].
Full-thickness abdominal defects following oncological
resection are considered a reconstructive challenge,especially when wide excision margins are required to
avoid cancer recurrence. Most advantageous reconstruct-
ive options may involve local, pedicled or free flap transfer
[3]. Local flaps may be either not available due to the
disease itself or jeopardized due to radiotherapy.
Pedicled superior or inferior rectus abdominis flap or
extended latissimus dorsi flap can be used for upper
abdominal wall reconstruction. In some cases (that is,
severely damaged local tissues), free tissue transfer may
be required for reconstruction [16]. Although free flaps
have some advantages as compared to pedicled flaps
such as more reliable healing, they also have some disad-
vantages including longer operative time, possible total
flap failure and distant donor site morbidity.
Reverse abdominoplasty may represent a valuable
alternative to pedicled or free flap reconstruction due to
its recruitment of the adjacent abdominal tissue into the
defect [17]. The inferior resection margin of the tumor
ablation represents the upper border of the flap, raised
below Scarpa’s fascia, above the rectus sheath. The
dissection then continues to the pubic area and the in-
ferior abdominal flap is then advanced cranially to cover
the upper abdominal wall defect. Despite its potential as
a reconstructive procedure, reverse abdominoplasty is
Figure 5 Skin defect closure with reverse abdominoplasty flap.
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[18,19] and rarely for reconstruction following onco-
logical resection [12,20,21]. Reverse abdominoplasty
can be used in combination with other flaps, or as soft
tissue coverage over a prosthetic mesh.
Based on our experience, we can therefore consider
reverse abdominoplasty a valuable surgical option whenFigure 6 Hematoxylin and eosin infiltration of gastric wall (a) by cells
neoplastic cells with pleomorphic nuclei and high nucleocytoplasmic
with vesicular nuclei, amphophilic cytoplasm, in a solid pattern of gro
cells with high CD56 membrane positivity suspicious for neuroendocrine dconfronting extraordinary parietal destruction as it
enables the surgeon to create a skin cover for an
abdominal wall defect. Considering that our patient
was elderly with skin laxity, we were able to obtain a large
inferior abdominal flap by employing this technique.
The above described clinical presentation of gastric can-
cer is quite rare and even rarer in the Western hemisphere.organized in a solid pattern with foci of necrosis (b) by
ratio, with a trabecular and organoid pattern; (c) by tumor cells
wth with central necrosis. (d) At immunohistochemistry neoplastic
ifferentiation.
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disciplinary approach involving the oncologist, surgeon
and radiation oncologist. This is particularly para-
mount when gastric cancer has an unfamiliar manifest-
ation such as in our reported case. When such rare
cases are presented, an even larger pool of specialists
has to be involved in the management of the disease. In
our experience we benefited from involving a plastic
surgeon in our integrated approach to patient treatment.
Although the reported case had an unsatisfactory out-
come and adversely ended with the death of the patient,
it is worth highlighting that this was not due to surgical
complication. The measurement of IAP has been incor-
porated routinely in critical units in order to monitor
and control those clinical situations that make us suspi-
cious of intra-abdominal hypertension (IAH). Abdominal
compartment syndrome (ACS) and IAH are increasingly
recognized as potential complications in patients in in-
tensive care units. ACS and IAH affect all body systems,
most notably the cardiac, respiratory, renal, and neuro-
logic systems. ACS/IAH affects blood flow to various
organs and plays a significant role in the prognosis of
the patients. Recognition of ACS/IAH, its risk factors
and clinical signs can reduce the morbidity and mortality
associated [22]. We used the intravesical measurement,
the most common method. In our case IAP was always
normal at intraoperative measurement and during post-
operative course. Indeed, as the planned and performed
surgery was the result of a collaboration between the
general and plastic surgeon, beyond focusing on the ex-
cisional components of the procedure (en bloc resection
of the tumor burden including stomach/colon/abdominal
wall), our approach was to frame the reconstructive issue,
which was carried out by implementing adequate surgical
techniques and devices. In conclusion, as our case study
attests, we are convinced of the utility and importance
of a multidisciplinary approach when confronted with
highly abnormal cancerous growths. We would like to
cite the additional file at the end of the case presenta-
tion as summary of the all the clinical history.
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